Company / Net Income
RenovoRx, Inc. Net Income History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$8.8M
FY2025
5-year range
-$10.2M / -$8.8M
FY2024-FY2025
Trend
+13.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$9M in FY2025.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 13.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.8M | +13.9% |
| FY2024 | -$10.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026